☰ ˟
Logo
Dallas / Ft. Worth – 214.277.9497 Los Angeles – 818.934.1774 Las Vegas – 800.310.4135
  • Home
  • What We Offer
    • Life Insurance
    • Mortgage Protection Insurance
    • Medicare
    • Disability Insurance
    • Retirement
    • Long-Term Care Insurance
    • Final Expense / Burial Insurance
    • Index Universal Life / Life Insurance Retirement Plan
    • Cancer / Heart Attack / Stroke Protection
    • Health Insurance
    • Group Health
    • Dental Insurance
    • Vision Insurance
    • Start Your Family Bank - Become your own Bank
  • Blog
  • About Us
    • About Us
    • Employee Directory
    • Testimonials
    • Privacy Policy
  • Become an Advisor
    • Become an Advisor
    • Secure Area
Home > Blog > Alzheimer's Drug Costs Spur Reconsideration of Medicare Part B Rate Hike
WEDNESDAY, MARCH 9, 2022

Alzheimer's Drug Costs Spur Reconsideration of Medicare Part B Rate Hike

 

The Biden administration is considering reducing the 15% hike for the standard Medicare Part B premium for this year after the maker of the new Alzheimer's drug Aduhelm announced that it would halve the price of the controversial medication.       

But after a preliminary decision by the Centers for Medicare and Medicaid Services (CMS) on Jan. 1 that it would limit coverage of Aduhelm to recipients in clinical trials for the medication, there may be calls for a larger rate cut. A final decision will be issued in April.

When setting Medicare Part B rates for 2022, the CMS expected outlays for Aduhelm had contributed to half of the jump in Part B premiums to $170.10 a month for 2022, from $148.50 in 2021.

That's despite not knowing at the time to what extent Medicare would cover the Biogen-manufactured drug. The extent was just decided with the most recent CMS announcement.

 

What is Aduhelm?

Aduhelm received Food and Drug Administration approval in July 2021, after which the company was roundly criticized for the cost of the drug, estimated at $56,000 a year. Then, in December, Biogen announced that it was cutting the annual price of the medication to $28,000.

As a result, Health and Human Services Secretary Xavier Becerra instructed the CMS to reassess this year's standard Part B premium increase.

"With the 50% price drop of Aduhelm on Jan. 1, there is a compelling basis for CMS to reexamine the previous recommendation," Becerra said in a prepared statement.

The CMS announced on Jan. 11 it would limit the use and coverage to people involved in clinical trials, because drugs that target amyloid beta plaques can also lead to brain bleeds.

As a result, it's even more likely that part of the rate hike will be reversed.

 

Why Medicare Part B?

Most drugs are covered by Medicare Part D, but it only covers medications that are prescribed and taken at home, not those that are administered in a health care setting, like a hospital.

Aduhelm is administered intravenously in a doctor's office and thus it would have been subject to Medicare Part B coverage. For now, that will only apply to people in clinical trials for the drug.

The vast majority of drugs prescribed to Alzheimer's patients under Medicare are covered under Part D. In 2017, about 2 million Medicare beneficiaries were prescribed drugs for Alzheimer's treatments covered under Part D, according to the Kaiser Family Foundation.

 

The fallout

As a result of the CMS decision, Medicare recipients who want access to the drug will have to try to get enrolled in a clinical trial or pay the full cost out of pocket. At $28,000 a year, that is almost as much as the average income of Medicare recipients.

Posted 10:51 AM

Tags: medicare, part b, retirement
Share |


No Comments


Post a Comment
Required
Required (Not Displayed)
Required


All comments are moderated and stripped of HTML.

NOTICE: This blog and website are made available by the publisher for educational and informational purposes only. It is not be used as a substitute for competent insurance, legal, or tax advice from a licensed professional in your state. By using this blog site you understand that there is no broker client relationship between you and the blog and website publisher.
Blog Archive
  • 2022
  • 2020
  • 2019
  • 2018
  • 2017

  • life insurance(13)
  • medicare(10)
  • insurance(6)
  • life insurance quote(5)
  • medicare supplements(4)
  • term insurance pay my mortgage off(3)
  • life insurance agent(3)
  • mortgage protection insurance(3)
  • iul policy(3)
  • new baby(3)
  • whole life(3)
  • what happens to my family if i die(3)
  • b(2)
  • c(2)
  • mortgage protection quote(2)
  • long term care(2)
  • covid-19(2)
  • and d?(2)
  • private mortgage insurance(2)
  • long term care insurance(2)
  • what is part c?(2)
  • retirement(2)
  • medicare in dallas(2)
  • disability insurance(2)
  • what is part a?(2)
  • turning 65(2)
  • dallas(2)
  • mortgage protection(2)
  • corona virus(2)
  • life insurance agent near me(2)
  • tx(2)
  • medicare advantage(2)
  • what is medicare part a(2)
  • pmi(2)
  • what is part b?(2)
  • term quote(2)
  • part b(2)
  • medicare in los angeles(2)
  • what is part d?(2)
  • permanent life insurance(2)
  • term insurance(2)
  • insurance agent near me(2)
  • how much does mortgage protection cost(2)
  • cash value insurance(1)
  • life insurance for kids(1)
  • saving for retirement(1)
  • aging(1)
  • senior care(1)
  • policy reviews(1)
  • what steps to take when turning 65(1)

View Mobile Version
Carrier
Carrier
Carrier
Carrier
Carrier
Carrier
Carrier
Logo

Ascension Group: 5717 Legacy Dr. Suite 250 Plano, TX 75024

Dallas – 214.277.9497

Los Angeles – 818.934.1774
Social Social Social Social Social
Home Page| Our Team| Join Our Newsletter| Refer A Friend| Become an Agent| Insurance Glossary| FAQs| Search Our Site
© Copyright. All rights reserved. Powered by Insurance Website Builder